COVID-19 Spike (4000nt) mRNA
COVID-19 Spike (4000nt) mRNA

100ug
HBPM00002-1
1mg
HBPM00002-2
Cat. No: HBPM00002
Technical Support

Product Overview


COVID-19 Spike (4000 nt) mRNA encodes the full-length Spike (S) protein of SARS-CoV-2, a critical structural protein involved in viral attachment and host cell entry. The Spike protein is located on the surface of the viral envelope and contains key antigenic regions recognized by the host immune system, making it one of the most widely studied targets in coronavirus research.


The SARS-CoV-2 Spike protein is commonly used in vaccine development studies, immune response evaluation, viral infection mechanism research, and therapeutic candidate screening. Full-length Spike mRNA provides a valuable research tool for studying protein expression, antigen production, and host-pathogen interactions in mammalian cell systems and animal models.


This product is synthesized through in vitro co-transcriptional capping technology and purified by precipitation and desalting processes. With a theoretical length of approximately 4,179 nt, COVID-19 Spike (4000 nt) mRNA enables efficient protein expression in eukaryotic mammalian cells and supports a wide range of molecular biology and translational research applications.



Amino Acid Sequence of Encoded Protein:


MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDPPEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT*



Key Features


Full-Length SARS-CoV-2 Spike Protein Encoding


Encodes the complete Spike (S) protein sequence of SARS-CoV-2, providing a comprehensive research model for studying viral antigen expression and immune-related mechanisms.


High Translation Efficiency


Produced using optimized mRNA synthesis technology to achieve efficient protein expression in mammalian cells for in vitro and in vivo research applications.


Excellent Product Stability


• Stable for up to 1 month under recommended storage conditions (2–8℃).

• Maintains performance after more than 10 freeze-thaw cycles.


Reliable Quality and Flexible Supply


• Short lead time to support research timelines.

• Customization services available for different research requirements.



Applications


COVID-19 Spike (4000 nt) mRNA is suitable for:

• SARS-CoV-2 Spike protein expression studies

• Vaccine antigen research and development

• Cellular immune response evaluation

• Viral infection mechanism studies

• Therapeutic candidate screening

• In vitro cell-based assays

• Animal model studies

• mRNA technology development and validation



Performance Data


mRNA Stability at 2–8℃



The product maintains structural integrity and functional activity during refrigerated storage, supporting short-term experimental preparation and transportation requirements.


Freeze-Thaw Stability Evaluation



COVID-19 Spike (4000 nt) mRNA demonstrates strong resistance to repeated freeze-thaw cycles, maintaining reliable performance after more than 10 freeze-thaw cycles.


Long-Term Stability at -80℃



The product maintains stability during long-term frozen storage at -80℃, ensuring consistent performance for extended research applications.



FAQ


Q1: What protein does COVID-19 Spike (4000 nt) mRNA encode?


A: This product encodes the full-length SARS-CoV-2 Spike (S) protein, which is involved in viral-host cell interaction and is widely studied as an antigen target.


Q2: What are the recommended storage conditions?


A: Recommended storage condition is -85℃ to -65℃.


Q3: How should the product be transported?


A: The product supports transportation conditions ranging from -45℃ to 25℃ with appropriate packaging.


Q4: Is customization available?


A: Yes. Customized mRNA sequences and production specifications can be provided according to research requirements.



Related Products

Catalog No. Product Name Concentration Packing Specifications
HBPM00001-1 COVID-19 RBD (1000nt) mRNA 1mg/mL 100ug
HBPM00001-2 1mg
HBPM00001-3 COVID-19 RBD (1000nt) mRNA (modified) 1mg/mL 100ug
HBPM00001-4 1mg
HBPM00001-5 COVID-19 RBD (1000nt) mRNA (for purification) 1mg/mL 1mg
HBPM00001-6 10mg
HBPM00002-1 COVID-19 Spike (4000nt) mRNA 1mg/mL 100ug
HBPM00002-2 1mg
HBPM00002-3 COVID-19 Spike (4000nt) mRNA (modified) 1mg/mL 100ug
HBPM00002-4 1mg
HBPM00002-5 COVID-19 Spike (4000nt) mRNA (for purification) 1mg/mL 1mg
HBPM00002-6 10mg
HBPM00003-1 eGFP mRNA 1mg/mL 100ug
HBPM00003-2 1mg
HBPM00003-3 eGFP mRNA (modified) 1mg/mL 100ug
HBPM00003-4 1mg
HBPM00003-5 500ug
HBPM00004-1 Fluc mRNA 1mg/mL 100ug
HBPM00004-2 1mg
HBPM00004-3 Fluc mRNA (modified) 1mg/mL 100ug
HBPM00004-4 1mg
HBPM00004-5 500ug
HBPM00005-1 mCherry mRNA 1mg/mL 100ug
HBPM00005-2 1mg
HBPM00005-3 mCherry mRNA (modified) 1mg/mL 100ug
HBPM00005-4 1mg
HBPM00006-1 Cas9 mRNA 1mg/mL 100μg
HBPM00006-2 1mg
HBPM00006-5 500ug
HBPM00006-3 Cas9 mRNA (modified) 1mg/mL 100μg
HBPM00006-4 1mg
HBPM00009-1 Human EPO mRNA (modified) 1mg/mL 100μg
HBPM00009-2 1mg
HBPM00009-3 Human EPO mRNA 1mg/mL 100μg
HBPM00009-4 1mg
HBPM00010-1 Mouse EPO mRNA (modified) 1mg/mL 100μg
HBPM00010-2 1mg
HBPM00010-3 Mouse EPO mRNA 1mg/mL 100μg
HBPM00010-4 1mg
HBPM00011-1 EGFP saRNA 1mg/mL 100μg
HBPM00011-2 1mg
HBPM00012-1 Fluc saRNA 1mg/mL 100μg
HBPM00012-2 1mg
HBPM00013-1 OVA mRNA (modified) 1mg/mL 100μg
HBPM00013-2 1mg
HBPM00014-1 Cre mRNA 1mg/mL 1mg
HBPM00014-2 100μg
HBPM00014-3 500μg
HBPM00014-4 Cre mRNA (modified) 1mg/mL 1mg
HBPM00014-5 100μg
HBPM00014-6 500μg
HBPM00015-1 MouseIL-12 mRNA 1mg/mL 100μg
HBPM00015-2 1mg
HBPM00015-3 MouseIL-12 mRNA (modified) 1mg/mL 100μg
HBPM00015-4 1mg
HBPM00101-1 circRNA eGFP 1mg/mL 100μg
HBPM00101-2 1mg
HBPM00102-1 circRNA Fluc 1mg/mL 100μg
HBPM00102-2 1mg
Message
Order Inquiry
Name *
Company *
Position *
Tel *
Mail *
Nation *

Do you have purchasing intention??

Requirement Description

Please contact on WhatsApp

Service Hotline: +86 400-808-5320

Large-scale production base: Building 6, Precision Medical Industry Base, Wuhan, China

Logistics & Supply Chain Center:417 Main St, Little Rock, AR 72201. United States.

Global Marketing Center: Hzymes Building, Fengxian District, Shanghai, China.

  • iso_copy_copy
  • iso_copy
  • iso
  • iso_copy_copy
  • iso_copy
  • iso
Contact Us

Service Hotline: +86 400-808-5320

Large-scale production base: Building 6, Precision Medical Industry Base, Wuhan, China.

Logistics & Supply Chain Center:417 Main St, Little Rock, AR 72201. United States.

Global Marketing Center: Hzymes Building, Fengxian District, Shanghai, China.

Copyright © Hzymes Biotechnology Co., Ltd. All Rights Reserved Web design

Site Map | Legal Notice | Privacy Policy |

Contact Us